(Q35927900)

11 August 2017

1 reference

title

Neonatal screening for glutaryl-CoA dehydrogenase deficiency (English)

1 reference

11 August 2017

Lindner M

1

1 reference

11 August 2017

Kölker S

2

1 reference

11 August 2017

Schulze A

3

1 reference

11 August 2017

Christensen E

4

1 reference

11 August 2017

Greenberg CR

5

1 reference

11 August 2017

Hoffmann GF

6

1 reference

11 August 2017

publication date

1 January 2004

1 reference

Journal of Inherited Metabolic Disease

11 August 2017

published in

1 reference

11 August 2017

volume

27

1 reference

11 August 2017

issue

6

1 reference

11 August 2017

page(s)

851-859

1 reference

https://scigraph.springernature.com/pub.10.1023/b:boli.0000045769.96657.af

11 August 2017

exact match

0 references

cites work

Emergency treatment in glutaryl-CoA dehydrogenase deficiency

1 reference

12 December 2020

The application of tandem mass spectrometry to neonatal screening for inherited disorders of intermediary metabolism

1 reference

12 December 2020

Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program

1 reference

12 December 2020

Glutaric acidemia, type I, missed by newborn screening in an infant with dystonia following promethazine administration

1 reference

12 December 2020

Screening newborns for inborn errors of metabolism by tandem mass spectrometry

1 reference

12 December 2020

Glutaric aciduria type 1 and neonatal screening: time to proceed?with caution

1 reference

12 December 2020

Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications

1 reference

12 December 2020

Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia

1 reference

12 December 2020

Maintenance treatment of glutaryl-CoA dehydrogenase deficiency.

1 reference

12 December 2020

Outcome of the first 3-years of a DNA-based neonatal screening program for glutaric acidemia type 1 in Manitoba and northwestern Ontario, Canada

1 reference

12 December 2020

Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency

1 reference

12 December 2020

Looking forward--an evidence-based approach to glutaryl-CoA dehydrogenase deficiency

1 reference

12 December 2020

Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I

1 reference

12 December 2020

Glutaryl-CoA Dehydrogenase Deficiency in Spain: Evidence of Two Groups of Patients, Genetically, and Biochemically Distinct

1 reference

12 December 2020

Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns

1 reference

12 December 2020

Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism.

1 reference

12 December 2020

10.1023/B:BOLI.0000045769.96657.AF

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

1002169902

0 references

1 reference